Therapeutic targets in chronic myeloid l
β
Nicholas B. Heaney; Tessa L. Holyoake
π
Article
π
2007
π
John Wiley and Sons
π
English
β 162 KB
## Abstract Chronic myeloid leukaemia (CML) is a clonal disorder of the haemopoietic stem cell arising as a consequence of the formation of the __bcrβabl__ oncogene. The particular molecular basis of this condition has enabled the development of therapies that selectively target diseased cells. The